Literature DB >> 1394213

Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase.

H P Emonard1, A G Remacle, A C Noël, J A Grimaud, W G Stetler-Stevenson, J M Foidart.   

Abstract

We have studied the capacity of two human breast adenocarcinoma cells, MDA-MB231 and MCF-7, to bind exogenous M(r) 72,000 type IV collagenase by both morphological and radioreceptor binding assays. By indirect immunofluorescence, staining with a specific anti-M(r) 72,000 type IV collagenase antibody was strongly induced when cells were preincubated with the purified enzyme. Scatchard plot analysis indicated the existence of a binding site for the M(r) 72,000 type IV collagenase with high affinity for both cell lines (Kd = 2 x 10(-9) M). These results are the first demonstration of the existence of a tumor cell membrane-associated putative receptor for a member of the matrix metalloproteinase family, as previously evidenced for the urokinase-type plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394213

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

Authors:  R Mazzieri; L Masiero; L Zanetta; S Monea; M Onisto; S Garbisa; P Mignatti
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

Review 2.  The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1997-02

3.  Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts.

Authors:  A Y Lee; K T Akers; M Collier; L Li; A Z Eisen; J L Seltzer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

4.  Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.

Authors:  M M Pacheco; M Mourão; E B Mantovani; I N Nishimoto; M M Brentani
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

5.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

6.  Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.

Authors:  C K Lindsay; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

7.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

Authors:  A Okada; J P Bellocq; N Rouyer; M P Chenard; M C Rio; P Chambon; P Basset
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  MT-MMP expression and localisation in human lung and breast cancers.

Authors:  M Polette; B Nawrocki; C Gilles; H Sato; M Seiki; J M Tournier; P Birembaut
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

Review 9.  Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.

Authors:  J R MacDougall; L M Matrisian
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

10.  Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.

Authors:  R Poulsom; A M Hanby; M Pignatelli; R E Jeffery; J M Longcroft; L Rogers; G W Stamp
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.